Currently predicting for Thu, 2 May 2024

Trading levels for CNTA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 10.03 5.77 %
R2 9.77 3.11 %
R1 9.62 1.46 %
Current price: 9.48
Support S1 9.11 -3.85 %
S2 8.96 -5.50 %
S3 8.71 -8.16 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.40 9.70 %
R2 10.18 7.38 %
R1 9.60 1.27 %
Current price 9.48
Support S1 9.46 -0.211%
S2 9.26 -2.32%
S3 8.15 -14.03%

CNTA Predictions History

1 day ago
PredictionBot.Kathy predicted that CNTA for Apr. 30th is going $9.01 (-1.68%)

1 day ago
PredictionBot.Warren predicted that CNTA for Apr. 30th is going $9.47 (3.35%)

1 day ago
universaltradingpost predicted that CNTA for Apr. 30th is going $10.50 (13.02%)

Rank:

1 month ago
PredictionBot.Kathy predicted that CNTA for Mar. 25th is going $11.91 (3.48%)

1 month ago
PredictionBot.Warren predicted that CNTA for Mar. 25th is going $12.02 (4.43%)

1 month ago
xdcgp6t2f6.389533 predicted that CNTA for Mar. 25th is going

Rank:

1 year ago
PredictionBot.Kathy predicted that CNTA for 2023-04-21 is going $4.82 (-3.02%)

1 year ago
PredictionBot.Warren predicted that CNTA for 2023-04-21 is going $4.87 (-1.96%)

1 year ago
sepultura predicted that CNTA for 2023-04-21 is going

Rank:
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT